Non-medical prescribing, patient group directions and minor ailment schemes in the treatment of drug misusers.
Walker M., Bell M. UK. National Health Service. National Treatment Agency for Substance Misuse.
NTA, 2007. 38p.
Web Address http://www.nta.nhs.uk/publications/documents/nta_non_medical_prescribing_1207.pdf

The Research Outcome Study in Ireland Evaluating Drug Treatment Effectiveness [ROSIE] baseline data report.
Comiskey C.M., Cox G. EIRE. National Advisory Committee on Drugs.
2007 xiii, 104p.
Web Address http://www.nacd.ie/publications/FINALReportROSIEBaseline%2012_10_07.pdf

Bouncing back! Exploring resilience, diversity and family in drug and alcohol prevention.
Adfam.
Adfam, 2007 40p.
Web Address http://www.adfam.org.uk/docets/Bpouncing%20Back!.pdf

Community-based interventions to reduce substance misuse among vulnerable and disadvantaged children and young people.
UK. National Health Service. National Institute for Health and Clinical Excellence.
NICE, 2007. 46p.
Web Address http://www.nice.org.uk/nicemedia/pdf/PHI004guidance.pdf

Report deaths related to drug poisoning in England and Wales, 2002-06.
UK. Office for National Statistics.
ONS, Health Statistics Quarterly Winter 2007 (36), 2007, p.66-72.

The economics of preventing drug use:  An introduction to the issues. 
Fordham R, Jones L, Sumnall H, McVeigh J and Bellis M.
NCCDP, 2007.
Web Address http://www.drugpreventionevidence.info/documentbank/economics_mar07.pdf

Barriers and incentives to treatment for illicit drug users with mental health comorbidities and complex vulnerabilities.
Holt M., Treloar C., McMillan K., Schultz L., Schultz M., Bath N. Australia. Commonwealth Department of Health and Ageing.
Commonwealth Department of Health and Ageing, 2007. 206p.
ISBN 1741864461

United Kingdom drug situation annual report to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). 2007 edition.
Eaton G., (ed.) Davies C., (ed.) English L, (ed.) Lodwick A., (ed.) Bellis M.A., (ed.) McVeigh J. (ed.) UK. Department of Health., Liverpool John Moores University. Centre for Public Health.
Liverpool John Moores University, 2007. 246p.

Reducing drug-related harm an action plan.
UK. Department of Health.
DoH, 2007 8p.
Web Address http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_074850

Methadone and buprenorphine for the management of opioid dependence.
UK. National Health Service. National Institute for Health and Clinical Excellence.
NICE, 2007. 37p.
Web Address http://www.guideline.gov/summary/summary.aspx?ss=15&doc_id=10483&nbr=5506

Naltrexone for managing opioid dependence.
UK. National Health Service. National Institute for Health and Clinical Excellence.
NICE, 2007. 5p.
Web Address http://www.nice.org.uk/nicemedia/pdf/word/TA115publicinfoword.doc

Supervised methadone in Staffordshire and Shropshire a study of factors associated with key outcome variables.
Bloor R. UK. National Health Service. National Treatment Agency for Substance Misuse.
NTA, 2007. 12p.
Web Address http://www.nta.nhs.uk/publications/documents/nta_rb21_nectos_summary.pdf

Crack user and carer consultation project.
Al-Rahman A., Craig D., Lamour P. UK. National Health Service. National Treatment Agency for Substance Misuse.
NTA, 2007 27p.
Web Address http://www.nta.nhs.uk/publications/documents/nta_crack_user_and_carer_consultation_project.pdf